Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

NCT01327911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Juxtafoveal Telangiectasia

Interventions

BIOLOGICAL: NT-501 implant

Sponsor

Neurotech Pharmaceuticals

Collaborators

[object Object]